Body Dysmorphic-Induced Androgenic Anabolic Steroids Usage and Its Association with Mental Health Outcomes: A Systematic Review
Poster Abstract
This systematic review on body dysmorphic disorder (BDD), anabolic-androgenic steroid (AAS) use, and mental health outcomes aim to examine the relationship between them. While looking at prior research, it has been suggested that individuals with BDD may be more likely to abuse AAS due to their preoccupation with appearance but, unfortunately, AAS use may worsen mental health issues in this population and exacerbate the issue. This systematic review will also discuss treatments that will help mitigate the effects of AAS on individuals with BDD. The review will include only published literature from a variety of databases such as PubMed, Scopus, Embase, and PsycINFO from 1992-2022. Two reviewers independently screened studies for inclusion criteria, extracted pertinent data, and assessed the quality of the evidence. The findings of this review will provide important insights into the complex relationship between BDD, AAS use, and mental health outcomes, and will inform future researchers and health practitioners on effective interventions and treatments for individuals with BDD who may be considering AAS use.
Body Dysmorphic-Induced Androgenic Anabolic Steroids Usage and Its Association with Mental Health Outcomes: A Systematic Review
This systematic review on body dysmorphic disorder (BDD), anabolic-androgenic steroid (AAS) use, and mental health outcomes aim to examine the relationship between them. While looking at prior research, it has been suggested that individuals with BDD may be more likely to abuse AAS due to their preoccupation with appearance but, unfortunately, AAS use may worsen mental health issues in this population and exacerbate the issue. This systematic review will also discuss treatments that will help mitigate the effects of AAS on individuals with BDD. The review will include only published literature from a variety of databases such as PubMed, Scopus, Embase, and PsycINFO from 1992-2022. Two reviewers independently screened studies for inclusion criteria, extracted pertinent data, and assessed the quality of the evidence. The findings of this review will provide important insights into the complex relationship between BDD, AAS use, and mental health outcomes, and will inform future researchers and health practitioners on effective interventions and treatments for individuals with BDD who may be considering AAS use.